FMN improves lipid profile in diabetes. FMN significantly reduced LDL (A), cholesterol (B), and triglyceride (C) levels in diabetic mice. Mice were fed with HFD for 9 weeks followed by two low doses of STZ injection (40 mg/kg) after diabetes was confirmed, mice were treated with 20 mg/kg FMN or 200 mg/kg metformin for 10 days, mice were then sacrificed, and serum collected for ELISA analysis. One-way ANOVA followed by Tukey post hoc, ***<0.001. VC; vehicle control.